- OptraLABS on Friday announced that its COVID-19 rapid test kit, called Optra-Shield, received approval from ICMR, as reported The Economic Times.
- The kits reportedly detect IgG antibodies which are developed a post-COVID-19 infection.
- "OptraLABS kits can be used at home or work. These kits are particularly useful to test the effect of the COVID-19 vaccine," said CEO Abhi Gholap.
- "We are not only manufacturing these in India but also made sure that our kits cost-effective. We are making Optra-Shield available at INR 350 in India," Gholap added.